AXL and neoplasm: Only a few de novo variants were passed on downstream; one example was an AXL mutation (p.A681L) in BaSq.4, detected at 15% allele frequency in a passage 3 subcutaneous tumor and later increasing to 25–37% in subsequent samples as well as in an FP sample that was derived from an upstream sample (p2).